FeaturesSignalPricingFounders
QB

Quaker BioVentures

Venture CapitalActive

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the

Philadelphia, United StatesFounded 2004
54
Investments
5
Exits
null
AUM
9.3%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Quaker BioVentures.

Get started free

Investment Thesis & Strategy

Quaker BioVentures is a venture capital firm that invests in life science companies, leading investments across various stages. They seek to invest in companies within the biotech and life science industries.

Investment Activity

Deals per year over the last 11 years

2
2000
0
2001
1
2002
1
2003
0
2004
1
2005
1
2006
0
2007
0
2008
0
2009
1
2010

Portfolio Companies

Selected investments from their portfolio of 54 companies

N
Neurocrine Biosciences
Biotech · Series A, 0
Active
A
Adolor Corporation
Biotech · Series A, 0
Active
V
ViroPharma
Biotech · Series A, 0
Active
N
Novavax
Biotech · Series A, 0
Active
M
MedImmune
Biotech · Series A, 0
Active
A
Aratana Therapeutics
Biotech · Series A, 2010
Active
C
Celator Pharmaceuticals
Biotech · Series A, 2006
Active
R
Regado Biosciences
Biotech · Series A, 2005
Active
A
Achillion Pharmaceuticals
Biotech · Series A, 2003
Active
I
Incyte
Biotech · Series A, 2002
Active
O
Optimer Pharmaceuticals
Biotech · Series A, 2000
Active
P
Pharmacyclics
Biotech · Series A, 2000
Active

Notable Exits

CompanyTypeYearValue / Acquirer
GenVecAcquisition2021—
Adolor CorporationAcquisition2011$1B
Arriva PharmaceuticalsAcquisition2008—
MedImmuneAcquisition2006$13.6B
IncyteIPO1999—

Frequently Asked Questions

Quaker BioVentures focuses on Series A, Series B, Series C+ stage investments.

Related Investors

EnerTech Capital

Philadelphia, United States · 71 deals

MissionOG

Philadelphia, United States · 42 deals

Karlani Capital

Philadelphia, United States · 23 deals

Quaker Partners

Philadelphia, United States · 15 deals

Gabriel Investments

Philadelphia, United States · 11 deals

Penn Medicine Co-Investment Fund

Philadelphia, United States · 9 deals